Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Solid Biosciences Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +1 vs. Q2 2023
- Shares held
- 16.2M
- −170.4K (−1.0%) vs. Q2 2023
- Total value
- $40.7M
- −$44.9M (−52.4%) vs. Q2 2023
- New holders
- 3
- 7 more added
- Sold out
- 2
- 9 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLDB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.14B |
| Q1 2026 | 150 | $717.4M |
| Q4 2025 | 132 | $459.2M |
| Q3 2025 | 129 | $505.2M |
| Q2 2025 | 116 | $403.4M |
| Q1 2025 | 125 | $293.2M |
| Q4 2024 | 90 | $145.3M |
| Q3 2024 | 92 | $249.8M |
| Q2 2024 | 80 | $213.2M |
| Q1 2024 | 56 | $465.9M |
| Q4 2023 | 40 | $102.2M |
| Q3 2023 | 37 | $40.7M |
| Q2 2023 | 36 | $85.6M |
| Q1 2023 | 39 | $74.8M |
| Q4 2022 | 35 | $85.6M |
| Q3 2022 | 58 | $33.4M |
| Q2 2022 | 67 | $39.5M |
| Q1 2022 | 78 | $83.3M |
| Q4 2021 | 82 | $132.2M |
| Q3 2021 | 91 | $184.3M |
| Q2 2021 | 92 | $293.4M |
| Q1 2021 | 104 | $437.6M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Solid Biosciences Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 3,495,933 | $8.81M | 0.30% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,426,286 | $8.63M | 0.17% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 3,130,422 | $7.89M | 0.88% | 00.0% | Unchanged |
| Camber Capital Management LP | 1,418,439 | $3.57M | 0.13% | 00.0% | Unchanged |
| Finepoint Capital LP | 961,251 | $2.42M | 1.21% | 00.0% | Unchanged |
| Laurion Capital Management LP | 928,169 | $2.34M | 0.06% | 00.0% | Unchanged |
| Artal Group S.A. | 909,219 | $2.29M | 0.10% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 646,604 | $1.63M | 0.01% | 00.0% | Unchanged |
| Great Point Partners LLC | 450,403 | $1.14M | 0.21% | −134,055−22.9% | Reduced |
| Vanguard Group Inc | 250,060 | $630.2K | 0.00% | +2,018+0.8% | Added |
| BlackRock Inc. | 131,283 | $330.8K | 0.00% | −6,761−4.9% | Reduced |
| Geode Capital Management, LLC | 102,513 | $258.4K | 0.00% | +13,254+14.8% | Added |
| Walleye Capital LLC | 91,109 | $229.6K | 0.00% | −1,994−2.1% | Reduced |
| Caas Capital Management LP | 64,112 | $161.6K | 0.04% | −37,569−36.9% | Reduced |
| Dimensional Fund Advisors LP | 55,090 | $138.8K | 0.00% | −7,074−11.4% | Reduced |
| Bridgeway Capital Management, LLC | 36,057 | $90.9K | 0.00% | +10,000+38.4% | Added |
| Renaissance Technologies LLC | 28,570 | $72.0K | 0.00% | +900+3.3% | Added |
| State Street Corp | 13,394 | $33.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,434 | $28.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,598 | $11.6K | 0.00% | −20−0.4% | Reduced |
| Barclays PLC | 4,417 | $11.1K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,548 | $6.00K | 0.00% | +1,413+124.5% | Added |
| Bank of America Corp | 2,326 | $5.86K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 2,332 | $5.00K | 0.00% | +116+5.2% | Added |
| Tower Research Capital LLC (TRC) | 1,488 | $3.75K | 0.00% | +1,488 | New |
| Manchester Capital Management LLC | 1,000 | $2.52K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 300 | $756 | 0.00% | +299+29,900.0% | Added |
| Group One Trading, L.P. | 214 | $539 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 133 | $335 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 133 | $335 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 69 | $174 | 0.00% | −56−44.8% | Reduced |
| Advisor Group Holdings, Inc. | 30 | $75 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 15 | $38 | 0.00% | −178−92.2% | Reduced |
| Parallel Advisors, LLC | 6 | $15 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 1 | $3 | 0.00% | +1 | New |
| Rhumbline Advisers | 0 | $2 | 0.00% | −27−100.0% | Reduced |
| Simplex Trading, LLC | 27 | $0 | 0.00% | +27 | New |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −12,083−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −66−100.0% | Sold out |